Kuan‐Ting ChenYen‐Chung ChenYu‐Hsi FanWen‐Xiu LinWun‐Cin LinYu‐Hsun WangLichi LinJeng‐Yuan ChiouJames C.‐C. Wei2026-01-292026-01-292017-12-1510.1111/1756-185X.13246https://scholars.csmu.edu.tw/handle/123456789/3626<jats:title>Abstract</jats:title><jats:sec><jats:title>Aim</jats:title><jats:p>Previous research demonstrated the possible relevance of dementia and rheumatic diseases. This population‐based study aims to investigate the association of rheumatic diseases and dementia.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The data of this case‐control study was extracted from the Taiwan National Health Insurance Research Database. Diagnosis of dementia and rheumatic diseases mentioned in this study were retrieved by the International Classification of Diseases‐9 code. We recruited cases (<jats:italic>n </jats:italic>=<jats:italic> </jats:italic>10 180) with dementia and controls (<jats:italic>n </jats:italic>=<jats:italic> </jats:italic>61 080) during 2000–2010, by matching on age, gender and index date with a match ratio 1 : 6. The Chi‐square test was used to calculate the baseline characteristics of the cases and controls for categorical variables such as age and gender. Simple conditional and multivariable conditional logistic regression models were used to estimate crude and adjusted odds ratios.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Statistical significance was observed in Sjögren's syndrome (<jats:styled-content style="fixed-case">SS</jats:styled-content>), systemic lupus erythematosus (<jats:styled-content style="fixed-case">SLE</jats:styled-content>), and osteoarthritis (<jats:styled-content style="fixed-case">OA</jats:styled-content>) among females (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>0.05 for <jats:styled-content style="fixed-case">SS</jats:styled-content> and <jats:styled-content style="fixed-case">SLE</jats:styled-content>;<jats:italic> P </jats:italic>&lt;<jats:italic> </jats:italic>0.01 for <jats:styled-content style="fixed-case">OA</jats:styled-content>), and in <jats:styled-content style="fixed-case">SS</jats:styled-content>, psoriatic arthritis (PsA) and <jats:styled-content style="fixed-case">OA</jats:styled-content> among males (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>0.01 for <jats:styled-content style="fixed-case">SS</jats:styled-content>;<jats:italic> P </jats:italic>&lt;<jats:italic> </jats:italic>0.05 for PsA and <jats:styled-content style="fixed-case">OA</jats:styled-content>). Further, we also demonstrated a significant difference in <jats:styled-content style="fixed-case">SLE</jats:styled-content> and <jats:styled-content style="fixed-case">OA</jats:styled-content> among the younger group (age = 40–64) (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>0.01 for <jats:styled-content style="fixed-case">SLE</jats:styled-content> and <jats:styled-content style="fixed-case">OA</jats:styled-content>), and in <jats:styled-content style="fixed-case">SS</jats:styled-content> and <jats:styled-content style="fixed-case">OA</jats:styled-content> among the older group (age ≧ 65) (<jats:italic>P </jats:italic>&lt;<jats:italic> </jats:italic>0.01 for <jats:styled-content style="fixed-case">SS</jats:styled-content> and <jats:styled-content style="fixed-case">OA</jats:styled-content>).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>In this population‐based case‐control study, we found that patients with rheumatoid arthritis, <jats:styled-content style="fixed-case">SS</jats:styled-content>,<jats:styled-content style="fixed-case"> SLE</jats:styled-content>, PsA and <jats:styled-content style="fixed-case">OA</jats:styled-content> are significantly associated with a higher risk of dementia than those without rheumatic diseases. We hypothesized that inflammation and medications are two possible mechanisms.</jats:p></jats:sec>Rheumatic diseases are associated with a higher risk of dementia: A nation‐wide, population‐based, case‐control studyjournal-article